StockData
Fortress Biotech, Inc. logo

Fortress Biotech, Inc. (FBIO) stock

FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$1.82+0.11 (+6.43%)

Close on Nov 17, 2026Market cap $66.94MP/E –Yield –

Fortress Biotech operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Fortress Biotech's operating cash flow for the twelve months ending Jun 30, 2026 was $125.92M. For fiscal 2025 it was -$65.78M. The highest annual figure on record is -$2.35M in fiscal 2009.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$65.78M–
FY2024Dec 31, 2024-$80.19M–
FY2023Dec 31, 2023-$128.23M–
FY2022Dec 31, 2022-$179.40M–
FY2021Dec 31, 2021-$116.54M–
FY2020Dec 31, 2020-$83.68M–
FY2019Dec 31, 2019-$94.96M–
FY2018Dec 31, 2018-$98.85M–
FY2017Dec 31, 2017-$81.31M–
FY2016Dec 31, 2016-$45.81M–
FY2015Dec 31, 2015-$20.38M–
FY2014Dec 31, 2014-$16.33M–
FY2013Dec 31, 2013-$29.65M–
FY2012Dec 31, 2012-$23.19M–
FY2011Dec 31, 2011-$10.95M–
FY2010Dec 31, 2010-$5.68M–
FY2009Dec 31, 2009-$2.35M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$59.28M–
Q1 FY2026Mar 31, 2026$203.85M–
Q4 FY2025Dec 31, 2025-$12.54M–
Q3 FY2025Sep 30, 2025-$6.11M–
Q2 FY2025Jun 30, 2025-$27.56M–
Q1 FY2025Mar 31, 2025-$19.56M–
Q4 FY2024Dec 31, 2024-$12.91M–
Q3 FY2024Sep 30, 2024-$20.06M–
Q2 FY2024Jun 30, 2024-$21.84M–
Q1 FY2024Mar 31, 2024-$25.39M–
Q4 FY2023Dec 31, 2023-$34.94M–
Q3 FY2023Sep 30, 2023-$16.78M–
Q2 FY2023Jun 30, 2023-$33.29M–
Q1 FY2023Mar 31, 2023-$43.22M–
Q4 FY2022Dec 31, 2022-$47.84M–
Q3 FY2022Sep 30, 2022-$43.27M–
Q2 FY2022Jun 30, 2022-$41.42M–
Q1 FY2022Mar 31, 2022-$46.86M–
Q4 FY2021Dec 31, 2021-$38.70M–
Q3 FY2021Sep 30, 2021-$21.70M–
Q2 FY2021Jun 30, 2021-$34.46M–
Q1 FY2021Mar 31, 2021-$21.69M–
Q4 FY2020Dec 31, 2020-$20.49M–
Q3 FY2020Sep 30, 2020-$23.89M–
Q2 FY2020Jun 30, 2020-$17.41M–
Q1 FY2020Mar 31, 2020-$21.89M–
Q4 FY2019Dec 31, 2019-$25.05M–
Q3 FY2019Sep 30, 2019-$16.26M–
Q2 FY2019Jun 30, 2019-$28.32M–
Q1 FY2019Mar 31, 2019-$25.33M–
Q4 FY2018Dec 31, 2018-$22.16M–
Q3 FY2018Sep 30, 2018-$24.76M–
Q2 FY2018Jun 30, 2018-$24.08M–
Q1 FY2018Mar 31, 2018-$27.84M–
Q4 FY2017Dec 31, 2017-$20.86M–
Q3 FY2017Sep 30, 2017-$25.09M–
Q2 FY2017Jun 30, 2017-$23.88M–
Q1 FY2017Mar 31, 2017-$11.48M–
Q4 FY2016Dec 31, 2016-$17.97M–
Q3 FY2016Sep 30, 2016-$8.82M–

More Fortress Biotech figures

See a number that looks wrong?